ジーエヌアイグループの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/05/02 | 2,374 | 2,433 | 2,353 | 2,415 | +25 | +1% | 1,233,300 |
| 2025/05/01 | 2,350 | 2,434 | 2,332 | 2,390 | +32 | +1.4% | 1,363,400 |
| 2025/04/30 | 2,320 | 2,387 | 2,303 | 2,358 | +76 | +3.3% | 1,954,200 |
| 2025/04/28 | 2,298 | 2,338 | 2,263 | 2,282 | -3 | -0.1% | 1,127,100 |
| 2025/04/25 | 2,258 | 2,329 | 2,224 | 2,285 | +48 | +2.1% | 1,528,500 |
| 2025/04/24 | 2,330 | 2,351 | 2,222 | 2,237 | +37 | +1.7% | 1,828,000 |
| 2025/04/23 | 2,225 | 2,248 | 2,174 | 2,200 | +10 | +0.5% | 1,752,500 |
| 2025/04/22 | 2,131 | 2,190 | 2,084 | 2,190 | +9 | +0.4% | 1,784,700 |
| 2025/04/21 | 2,200 | 2,248 | 2,169 | 2,181 | -46 | -2.1% | 2,416,600 |
| 2025/04/18 | 2,069 | 2,227 | 2,018 | 2,227 | +245 | +12.4% | 3,967,800 |
| 2025/04/17 | 1,788 | 1,987 | 1,782 | 1,982 | +192 | +10.7% | 2,120,500 |
| 2025/04/16 | 1,841 | 1,856 | 1,778 | 1,790 | -38 | -2.1% | 1,061,400 |
| 2025/04/15 | 1,849 | 1,863 | 1,813 | 1,828 | +12 | +0.7% | 631,400 |
| 2025/04/14 | 1,830 | 1,868 | 1,816 | 1,816 | +9 | +0.5% | 1,031,000 |
| 2025/04/11 | 1,727 | 1,807 | 1,692 | 1,807 | -28 | -1.5% | 2,294,200 |
| 2025/04/10 | 1,834 | 1,854 | 1,802 | 1,835 | +224 | +13.9% | 1,985,900 |
| 2025/04/09 | 1,667 | 1,705 | 1,560 | 1,611 | -95 | -5.6% | 3,159,600 |
| 2025/04/08 | 1,680 | 1,723 | 1,650 | 1,706 | +216 | +14.5% | 2,081,800 |
| 2025/04/07 | 1,478 | 1,614 | 1,469 | 1,490 | -251 | -14.4% | 4,319,900 |
| 2025/04/04 | 1,846 | 1,860 | 1,636 | 1,741 | -141 | -7.5% | 5,249,300 |
| 2025/04/03 | 1,871 | 1,948 | 1,860 | 1,882 | -85 | -4.3% | 2,866,600 |
| 2025/04/02 | 2,016 | 2,040 | 1,967 | 1,967 | -89 | -4.3% | 2,186,100 |
| 2025/04/01 | 2,050 | 2,080 | 2,039 | 2,056 | -38 | -1.8% | 1,496,200 |
| 2025/03/31 | 2,168 | 2,169 | 2,082 | 2,094 | -103 | -4.7% | 2,155,300 |
| 2025/03/28 | 2,203 | 2,278 | 2,180 | 2,197 | +66 | +3.1% | 2,808,300 |
| 2025/03/27 | 2,116 | 2,251 | 2,112 | 2,131 | -26 | -1.2% | 2,897,100 |
| 2025/03/26 | 2,209 | 2,216 | 2,143 | 2,157 | -52 | -2.4% | 1,843,900 |
| 2025/03/25 | 2,250 | 2,258 | 2,133 | 2,209 | -104 | -4.5% | 4,632,800 |
| 2025/03/24 | 2,359 | 2,373 | 2,283 | 2,313 | -28 | -1.2% | 1,567,600 |
| 2025/03/21 | 2,390 | 2,426 | 2,341 | 2,341 | +16 | +0.7% | 2,126,400 |
| 2025/03/19 | 2,394 | 2,478 | 2,311 | 2,325 | -177 | -7.1% | 3,131,900 |
| 2025/03/18 | 2,480 | 2,524 | 2,375 | 2,502 | -75 | -2.9% | 3,174,500 |
| 2025/03/17 | 2,540 | 2,606 | 2,491 | 2,577 | +37 | +1.5% | 1,565,500 |
| 2025/03/14 | 2,475 | 2,555 | 2,437 | 2,540 | +68 | +2.8% | 1,679,200 |
| 2025/03/13 | 2,502 | 2,534 | 2,446 | 2,472 | -29 | -1.2% | 1,845,000 |
| 2025/03/12 | 2,430 | 2,543 | 2,426 | 2,501 | +161 | +6.9% | 2,836,100 |
| 2025/03/11 | 2,206 | 2,382 | 2,123 | 2,340 | +51 | +2.2% | 5,049,800 |
| 2025/03/10 | 2,263 | 2,405 | 2,217 | 2,289 | -162 | -6.6% | 5,411,900 |
| 2025/03/07 | 2,467 | 2,558 | 2,424 | 2,451 | -108 | -4.2% | 2,796,500 |
| 2025/03/06 | 2,556 | 2,687 | 2,381 | 2,559 | +84 | +3.4% | 8,270,700 |
| 2025/03/05 | 3,145 | 3,160 | 2,475 | 2,475 | -700 | -22% | 12,081,700 |
| 2025/03/04 | 3,335 | 3,345 | 3,140 | 3,175 | -195 | -5.8% | 1,165,300 |
| 2025/03/03 | 3,375 | 3,440 | 3,350 | 3,370 | -5 | -0.1% | 628,900 |
| 2025/02/28 | 3,375 | 3,525 | 3,350 | 3,375 | -70 | -2% | 839,500 |
| 2025/02/27 | 3,680 | 3,690 | 3,350 | 3,445 | -295 | -7.9% | 1,590,000 |
| 2025/02/26 | 3,730 | 3,845 | 3,715 | 3,740 | +20 | +0.5% | 747,300 |
| 2025/02/25 | 3,650 | 3,745 | 3,575 | 3,720 | -95 | -2.5% | 1,018,600 |
| 2025/02/21 | 3,850 | 3,915 | 3,780 | 3,815 | -70 | -1.8% | 911,900 |
| 2025/02/20 | 3,615 | 3,970 | 3,600 | 3,885 | +200 | +5.4% | 1,938,000 |
| 2025/02/19 | 3,750 | 3,765 | 3,645 | 3,685 | +60 | +1.7% | 1,099,700 |
1～
50
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「ジーエヌアイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ジーエヌアイ | 241,500円 | +21.7% | +999.9% | 0.00% | 10.06倍 | 3.33倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 東和薬品 | 263,700円 | +15.0% | -7.3% | 2.65% | 8.65倍 | 0.82倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| ゼリア新薬 | 234,300円 | +14.2% | +41.0% | 1.96% | 11.48倍 | 1.17倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 持田薬 | 309,000円 | +3.0% | +27.5% | 2.59% | 19.56倍 | 0.85倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| 杏林製薬 | 148,600円 | +8.8% | +99.9% | 3.50% | 9.49倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム
